Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 7, 2023
Burden of Illness and Treatment Patterns Among Patients With von Willebrand Disease in US Clinical PracticeElyse Swallow, Jessica R Marden, Emma Billmyer, et al.
Journal of Patient Experience|July 9, 2025
Preferences of Patients With cTTP and Other Chronic Conditions for At-Home Prophylactic Infusions: A Discrete Choice ExperimentLaurie Batchelder, Montserrat Casamayor, Ana María Rodríguez, et al.
Current Medical Research and Opinion|July 4, 2007
Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilizationShawn X Sun, Kwan Y Lee, Carl T Bertram, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 3, 2015
Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage populationKeran Moll, Shawn X Sun, Jeffrey J Ellis, et al.
Current Medical Research and Opinion|September 29, 2011
Health-related quality of life, work productivity and health care resource use associated with constipation predominant irritable bowel syndromeMarco DiBonaventura, Shawn X Sun, Susan C Bolge, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 28, 2015
A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real worldYin Wan, Shawn X Sun, Shelby Corman, et al.
Pageof 4